financetom
Business
financetom
/
Business
/
Novo Nordisk gets UK approval for using weight-loss drug to reduce heart risks
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novo Nordisk gets UK approval for using weight-loss drug to reduce heart risks
Jul 23, 2024 8:00 AM

July 23 (Reuters) - Novo Nordisk's

weight-loss drug Wegovy has secured the UK regulator's approval

for its use to reduce the risk of overweight and obese adults

suffering serious heart problems or strokes, the agency said on

Tuesday.

(Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved